云南春招网
云南春招

中国临床医学研究发展现状与未来展望

浏览数:12 
中国临床医学研究发展现状与未来展望
袁天蔚1△,李萍萍2△,李苏宁2,尹军祥2,范月蕾1,熊燕1,陈书安2,范玲2*
1. 中国科学院上海生命科学信息中心,上海 2000312. 中国生物技术发展中心,北京 100039
摘要:
近年来,中国在临床医学研究方面进行了多项规划与布局并取得了较好的成效。为系统反映中国临床医学研究发展现状,分析我国临床研究整体水平,本文梳理了全球及中国的临床医学研究论文、临床试验、技术转化等现状,分析了中国在临床医学产业链中的竞争力水平。调研结果显示,2018年中国临床医学论文数量已达全球第二,主持或参与的临床试验数量达全球第三。总体来看,中国目前尚缺乏高质量、系统性的临床医学研究体系和具有全球影响力的研究成果,在具有自主知识产权的临床药物数量、主导国际诊疗标准和制定临床规范等方面,与发达国家还具有明显差距。未来,仍需要进一步加强对临床医学研究领域的顶层设计,促进临床研究与基础研究的转化结合以及跨学科交叉融合,激发产业链各端的科技创新活力,推动医学成果转化,助力实现健康中国战略。
关键词:   临床医学   临床研究   竞争力分析   计量分析
DOI:10.12025/j.issn.1008-6358.2019.20191792
分类号:R-1
基金项目:

Current status and future perspective of clinical medical research in China


Abstract:
In recent years, China has carried out a number of strategies and initiatives in clinical medicine and achieved good results. In order to investigate the clinical research status and competitiveness of China, the research articles, clinical trials, and medical products were comprehensively analyzed. The competitiveness of each part in the medical industry chain was analyzed independently. As results, the number of clinical research articles in China has reached the second place in 2018, while the number of clinical trials have reached the third place of all countries in the world. However, there are obvious gaps between China and developed countries due to the insufficiency of systematic clinical research, high-quality breakthrough with global impact, new drugs with independent intellectual property, international clinical guidance led by Chinese institutes. In future, the policy makers should make strategies to find pathways for transformation and stimulating scientific innovation and achievements transformation in the industrial chain.
Key words:   clinical medicine   clinical research   competitiveness analysis   biblimetric analysis


               @昆明-云南春招网 
   云南春招教育咨询服务中心 版权所有
邮编:650000    电话:0871—65032626